Cited by 364Cannabis and Cannabinoid ResearchMedicinal Plant Extracts EffectsAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Effects of ipsapirone and cannabidiol on human experimental anxiety

Zuardi, A. W., Cosme, R. A., Graeff, F. G., Guimarães, F. S.·1993·Journal of Psychopharmacology

DOI 10.1177/026988119300700112

Open this paper in CoChat — free account

Abstract

The effects of ipsapirone and cannabidiol (CBD) on healthy volunteers submitted to a simulated public speaking (SPS) test were compared with those of the anxiolytic benzodiazepine diazepam and placebo. Four independent groups of 10 subjects received, under a double-blind design, placebo or one of the following drugs: CBD (300 mg), diazepam (10 mg) or ipsapirone (5 mg). Subjective anxiety was evaluated through the Visual Analogue Mood Scale (VAMS) and the State-trait Anxiety Inventory (STAI). The VAMS anxiety factor showed that ipsapirone attenuated SPS-induced anxiety while CBD decreased anxiety after the SPS test. Diazepam, on the other hand, was anxiolytic before and after the SPS test, but had no effect on the increase in anxiety induced by the speech test. Only ipsapirone attenuated the increase in systolic blood pressure induced by the test. Significant sedative effects were only observed with diazepam. The results suggest that ipsapirone and CBD have anxiolytic properties in human volunteers submitted to a stressful situation.

Integrity signals

Registry

Crossref · 10.1177/026988119300700112

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Untitled work
(1970) · Cited by 24,983
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Manual for the Wechsler Adult Intelligence Scale.
Wechsler, D. (1955) · Psychological Corp. eBooks · Cited by 4,941
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
The use of analogue scales in rating subjective feelings
BOND, A., & LADER, M. (1974) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1974.tb02285.x · Cited by 1,972
The development of a scale to measure fear
Geer, J. H. (1965) · Behaviour Research and Therapy · doi:10.1016/0005-7967(65)90040-9 · Cited by 777
Action of cannabidiol on the anxiety and other effects produced by ?9-THC in normal subjects
Zuardi, A. W., Shirakawa, I., Finkelfarb, E., & Karniol, I. G. (1982) · Psychopharmacology · doi:10.1007/bf00432554 · Cited by 608
Chronic Administration of Cannabidiol to Healthy Volunteers and Epileptic Patients
Cunha, J. M., Carlini, E. A., Pereira, A. E., Ramos, O. L., Pimentel, C., Gagliardi, R. J., Sanvito, W. L., Lander, N., & Mechoulam, R. (2008) · Pharmacology · doi:10.1159/000137430 · Cited by 570
Pharmacology of Marihuana
Pertwee, R. G. (1977) · Neuroscience · doi:10.1016/0306-4522(77)90080-x · Cited by 384
The action of sedatives on brain stem oculomotor systems in man
Norris, H. (1971) · Neuropharmacology · doi:10.1016/0028-3908(71)90039-6 · Cited by 384

Show all 39 references

Research works printed but not linked: 10

Biaggio A M B, 1976, Cross-cultural research on anxiety., 29
Critchley M A E, 1987, Br J Pharmacol, 92, 660
Geer J H, 1965, Behav Res Ther, 193, 785
Gregg J M, 1976, J Oral Surg, 34, 301
Guimarães F S, 1989, Brazilian J Med Biol Res, 22, 1083
Higgins G A, 1987, Br J Pharmacol, 92, 658P
Kuemmel B, 1988, Psychopharmacology, 96, 353, 10.1007/BF00216061 · DOI
Norusis M J, 1988, SPSS/PC + advanced stataistics V. 2.0
Zuardi A W, 1981, J Brasileiro Psiquiatr, 131, 403
Zuardi A W, 1983, Ar Biol Technol, 26, 391

Sorted by citations

Items 201–300 of 362

Pharmacokinetics, Safety, and Tolerability of a Medicinal Cannabis Formulation in Patients with Chronic Non-cancer Pain on Long-Term High Dose Opioid Analgesia: A Pilot Study
Bonomo, Y. A., Norman, A. F., Collins, L., O’Neill, H., Galettis, P., Trinca, J., Strauss, N. H. M., Martin, J. H., & Castle, D. J. (2021) · Pain and Therapy · doi:10.1007/s40122-021-00344-y · Cited by 22
Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemic
Souza, J. D. S., Zuardi, A. W., Guimarães, F. S., Osório, F. D. L., Loureiro, S. R., Campos, A. C., Hallak, J. E. C., SANTOS, R. G. D., Silveira, I. L. M., Pereira‐Lima, K., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.856846 · Cited by 21
The NLRP3 Inflammasome in Stress Response: Another Target for the Promiscuous Cannabidiol
dos Santos, A. H., Vila-Verde, C., Guimarães, F. S., Joca, S. R. L., & Lisboa, S. F. D. S. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220411101217 · Cited by 20
Effects of tryptophan depletion on anxiety induced by simulated public speaking
Monteiro-dos-Santos, P. C., Graeff, F. G., Dos-Santos, J. E., Ribeiro, R., Guimarães, F. S., & Zuardi, A. W. (2000) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2000000500013 · Cited by 20
Comparison of acute and repeated treatment with the 5‐HT1A receptor ligands 8‐OH‐DPAT and ipsapirone in animal models of anxiety and depression
Vry, J. D., & Schreiber, R. (1993) · Drug Development Research · doi:10.1002/ddr.430300208 · Cited by 19
Neurocognitive effects of cannabis: Lessons learned from human experimental studies
Colizzi, M., & Bhattacharyya, S. (2018) · Progress in brain research · doi:10.1016/bs.pbr.2018.08.010 · Cited by 19
Therapeutic Potential for Cannabinoids in Sports Medicine: Current Literature Review
Naik, H., & Trojian, T. H. (2021) · Current Sports Medicine Reports · doi:10.1249/jsr.0000000000000858 · Cited by 19
Efficiency of Inhaled Cannabidiol in Cannabis Use Disorder: The Pilot Study Cannavap
Cleirec, G., Desmier, E., Lacatus, C., Lesgourgues, S., Braun, A., Peloso, C., & Obadia, C. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.899221 · Cited by 18
Therapeutic Effects of Cannabinoids and Their Applications in COVID-19 Treatment
Pérez, R., Glaser, T., Villegas, C., Burgos, V., Ulrich, H., & Paz, C. (2022) · Life · doi:10.3390/life12122117 · Cited by 20
Experimental models for the evaluation of speech and public speaking anxiety: A critical review of the designs adopted.
Osório, F. D. L., Crippa, J. A. S., & Loureiro, S. R. (2008) · The Journal of Speech and Language Pathology – Applied Behavior Analysis · doi:10.1037/h0100236 · Cited by 17
Altered relationship between cortisol response to social stress and mediotemporal function during fear processing in people at clinical high risk for psychosis: a preliminary report
Davies, C., Appiah‐Kusi, E., Wilson, R. P., Blest‐Hopley, G., Bossong, M. G., Valmaggia, L., Brammer, M. J., Pérez, J., Allen, P., Murray, R. M., et al. (2021) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-021-01318-z · Cited by 18
Chronic Effects of Effective Oral Cannabidiol Delivery on 24-h Ambulatory Blood Pressure and Vascular Outcomes in Treated and Untreated Hypertension (HYPER-H21-4): Study Protocol for a Randomized, Placebo-Controlled, and Crossover Study
Kumrić, M., Božić, J., Dujić, G., Vrdoljak, J., & Dujić, Ž. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12071037 · Cited by 17
The effects of Cannabidiol (CBD) and Delta-9-Tetrahydrocannabinol (THC) on the recognition of emotions in facial expressions: A systematic review of randomized controlled trials
Rossi, G. N., Osório, F. D. L., Morgan, C. J. A., Crippa, J. A. S., Bouso, J. C., Rocha, J. M., Zuardi, A. W., Hallak, J. E. C., & SANTOS, R. G. D. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.07.034 · Cited by 17
Systematic literature review of human studies assessing the efficacy of cannabidiol for social anxiety
Fliegel, D. K., & Lichenstein, S. D. (2022) · Psychiatry Research Communications · doi:10.1016/j.psycom.2022.100074 · Cited by 20
Withdrawal of plasma estradiol is associated with increased anxiety reported by women in the first 12 hours after delivery
de Rezende, M. G., Garcia-Leal, C., de Sá, M. F. S., Cavalli, R. D. C., & Del‐Ben, C. M. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.11.006 · Cited by 16
Modulation of the Endocannabinoid and Oxytocinergic Systems as a Potential Treatment Approach for Social Anxiety Disorder
SANTOS, R. G. D., Osório, F. D. L., Martín‐Santos, R., Zuardi, A. W., Hallak, J. E. C., & Crippa, J. A. S. (2019) · CNS Drugs · doi:10.1007/s40263-019-00669-5 · Cited by 17
Effect of two oral formulations of cannabidiol on responses to emotional stimuli in healthy human volunteers: pharmaceutical vehicle matters
Crippa, J. A. S., Pereira, L. C., Pereira, L. C., Zimmermann, P. M. D. R., Brum, L., Rechia, L. M., Dias, I. C. D. S., Hallak, J. E. C., Campos, A. C., Guimarães, F. S., et al. (2021) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2020-1684 · Cited by 16
Modulation of cognitive and emotional processing by cannabidiol: the role of the anterior cingulate cortex
Kowal, M. A., Hazekamp, A., Colzato, L. S., van Steenbergen, H., & Hommel, B. (2013) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2013.00147 · Cited by 16
Cannabidiol Oil Ingested as Sublingual Drops or Within Gelatin Capsules Shows Similar Pharmacokinetic Profiles in Healthy Males
Johnson, D. A., Funnell, M. P., Heaney, L. M., Cable, T. G., Wheeler, P. C., Bailey, S. J., Clifford, T., & James, L. J. (2023) · Cannabis and Cannabinoid Research · doi:10.1089/can.2023.0117 · Cited by 15
A narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disorders
Omotayo, O. P., Lemmer, Y., & Mason, S. (2024) · Journal of Cannabis Research · doi:10.1186/s42238-024-00222-2 · Cited by 21
Synthetic cannabinoids
Freund, S. A., & Banning, A. S. (2017) · JAAPA · doi:10.1097/01.jaa.0000525914.28344.e2 · Cited by 15
Effects of ascorbic acid on anxiety state and affect in a non-clinical sample
Moritz, B., Schwarzbold, M. L., Guarnieri, R., Díaz, A. P., Rodrigues, A. L. S., & Dafré, A. L. (2017) · Acta Neurobiologiae Experimentalis · doi:10.21307/ane-2017-068 · Cited by 14
An open-label feasibility trial of transdermal cannabidiol for hand osteoarthritis
Bawa, Z., Lewis, D., Gavin, P. D., Libinaki, R., Joubran, L., El-Tamimy, M., Taylor, G., Meltzer, R., Bedoya‐Pérez, M. A., Kevin, R. C., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-62428-x · Cited by 15
Cannabidiol Interferes with Establishment of Δ 9 -Tetrahydrocannabinol-Induced Nausea Through a 5-HT 1A Mechanism
DeVuono, M. V., Caprara, O. L., Petrie, G. N., Limebeer, C. L., Rock, E. M., Hill, M. N., & Parker, L. A. (2020) · Cannabis and Cannabinoid Research · doi:10.1089/can.2020.0083 · Cited by 14
Cannabidiol provides viable treatment opportunity for multiple neurological pathologies of autism spectrum disorder
Gu, B. (2017) · Global Drugs and Therapeutics · doi:10.15761/gdt.1000134 · Cited by 14
Denying renal transplantation to an adolescent medical cannabis user: An ethical case study
Ryan, J. E., Noeder, M. M., Burke, C., Stubblefield, S., Sulieman, S. E., & Miller, E. G. (2019) · Pediatric Transplantation · doi:10.1111/petr.13467 · Cited by 14
Interactive Effects of Ayahuasca and Cannabidiol in Social Cognition in Healthy Volunteers
Rossi, G. N., Rocha, J. M., Osório, F. D. L., Bouso, J. C., Oña, G., Silveira, G. D. O., Yonamine, M., Bertozi, G., Crevelin, E. J., Queiroz, M. E. C., et al. (2023) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001691 · Cited by 14
The Effectiveness and Safety of Cannabidiol in Non-seizure-related Indications: A Systematic Review of Published Randomized Clinical Trials
Tang, Y., Tonkovich, K., & Rudisill, T. M. (2022) · Pharmaceutical Medicine · doi:10.1007/s40290-022-00446-8 · Cited by 13
Effect ofd-fenfluramine on human experimental anxiety
Hetem, L. A. B., de Souza, C. J., Zuardi, A. W., Guimarães, F. S., & Graeff, E. G. (1996) · Psychopharmacology · doi:10.1007/bf02806003 · Cited by 13
The Influence of Oral Cannabidiol on 24-h Ambulatory Blood Pressure and Arterial Stiffness in Untreated Hypertension: A Double-Blind, Placebo-Controlled, Cross-Over Pilot Study
Dragun, T., Brown, C. V., Tulppo, M. P., Obad, A., & Dujić, Ž. (2023) · Advances in Therapy · doi:10.1007/s12325-023-02560-8 · Cited by 12
Sex and estrous cycle-linked differences in the effect of cannabidiol on panic-like responding in rats and mice
Hernandes, P. M., Batistela, M. F., Nascimento‐Silva, J. M., Frias, A. T., Matthiesen, M., Campos, A. C., Lovick, T. A., & Zangrossi, H. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114663 · Cited by 12
Social Psychopharmacology: Novel Approaches to Treat Deficits in Social Motivation in Schizophrenia
Bershad, A. K., & de Wit, H. (2023) · Schizophrenia Bulletin · doi:10.1093/schbul/sbad094 · Cited by 12
Role of Cannabinoid Receptors in Anxiety Disorders
Degroot, A. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3_24 · Cited by 12
Cannabidiol and the corticoraphe circuit in post-traumatic stress disorder
Alexander, C., & Vasefi, M. (2021) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2021.08.001 · Cited by 12
Cannabidiol for Scan-Related Anxiety in Women With Advanced Breast Cancer
Nayak, M. M., Chai, P. R., Catalano, P. J., Pirl, W. F., Tulsky, J. A., Tung, S. C., Lin, N., Andrade, N., Johns, S., Vaz, C., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.50391 · Cited by 11
Cannabidiol and 5-HT1A Receptors
Fogaça, M. V., Campos, A. C., & Guimarães, F. S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800213-1.00070-5 · Cited by 11
The Effect of Single-Dose Massage Session on Autonomic Activity, Mood, and Affective Responses in Major Depressive Disorder
Hohl, R., Deslandes, A. C., & Mármora, C. H. C. (2019) · Journal of Holistic Nursing · doi:10.1177/0898010119832493 · Cited by 11
Clinical Approaches to Cannabis
Slawek, D. E., Curtis, S. A., Arnsten, J. H., & Cunningham, C. O. (2021) · Medical Clinics of North America · doi:10.1016/j.mcna.2021.08.004 · Cited by 11
Distinct Effects of D9-tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing
Fusar‐Poli, P. (2009) · European Psychiatry · doi:10.1016/s0924-9338(09)70439-0 · Cited by 11
Cannabidiol (CBD) potentiates physiological and behavioral markers of hypothalamic–pituitary–adrenal (HPA) axis responsivity in female and male mice
Jenkins, B. W., Spina, H. A., Nicholson, K., Newman, A. E. M., & Khokhar, J. Y. (2025) · Psychopharmacology · doi:10.1007/s00213-024-06737-z · Cited by 10
Serotonin 2A receptors and cannabinoids
Ibarra‐Lecue, I., Dı́ez-Alarcia, R., & Urigüen, L. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.01.004 · Cited by 11
Cannabis and Anxiety: a Biopsychosocial Model
Walukevich‐Dienst, K., Crapanzano, K. A., Lewis, E. M., & Buckner, J. D. (2019) · Current Addiction Reports · doi:10.1007/s40429-019-00284-w · Cited by 12
Trends in Antidepressant, Anxiolytic, and Cannabinoid Use Among Italian Elite Athletes (2011–2023): A Longitudinal Anti-Doping Analysis
Ruggiero, M., FERRANTE, L., Tafuri, D., Meccariello, R., & Mazzeo, F. (2025) · Sports · doi:10.3390/sports13070233 · Cited by 11
Effect of aerosolized nicotine on human bronchial epithelial cells is amplified after co-administration with cannabidiol (CBD): a pilot in vitro study
Leigh, N. J., & Goniewicz, M. L. (2020) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-020-00418-1 · Cited by 10
The Construct of Medical and Non-Medical Marijuana—Critical Review
Silczuk, A., Smułek, D., Kołodziej, M., & Gujska, J. H. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19052769 · Cited by 9
Effects of intranasal oxytocin on the self-perception and anxiety of singers during a simulated public singing performance: A randomized, placebo-controlled trial
Osório, F. D. L., Rojas, G. V. E., & AGUIAR-RICZ, L. N. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.943578 · Cited by 9
Therapeutic potential of CBD in Autism Spectrum Disorder
Pedrazzi, J. F. C., Hassib, L., Ferreira, F. R., Hallak, J. E. C., Del-Bel, E., & Crippa, J. A. S. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.05.002 · Cited by 12
Effects of diazepam on hippocampal blood flow in people at clinical high risk for psychosis
Livingston, N. R., Kiemes, A., Devenyi, G. A., Knight, S., Lukow, P. B., Jelen, L. A., Reilly, T. J., Dima, A., Nettis, M. A., Casetta, C., et al. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01864-9 · Cited by 10
Investigation on the neuroprotective effect of a cannabidiol-enriched non-psychotropic Cannabis sativa L. extract in an in vitro model of excitotoxicity
Borgonetti, V., Biagi, M., Galeotti, N., Manetti, F., & Governa, P. (2022) · Fitoterapia · doi:10.1016/j.fitote.2022.105315 · Cited by 8
The effects of a brand-specific, hemp-derived cannabidiol product on physiological, biochemical, and psychometric outcomes in healthy adults: a double-blind, randomized clinical trial
Mastrofini, G. F., McFadden, B. A., Chandler, A. J., Lints, B. S., Cintineo, H. P., Rhoades, N., Vincenty, C. S., Stray-Gundersen, S. O., Lane‐Cordova, A. D., & Arent, S. M. (2024) · Journal of the International Society of Sports Nutrition · doi:10.1080/15502783.2024.2370430 · Cited by 8
Review of the current ongoing clinical trials exploring the possible anti-anxiety effects of cannabidiol
Bhuller, R., Schlage, W. K., & Hoeng, J. (2024) · Journal of Cannabis Research · doi:10.1186/s42238-024-00250-y · Cited by 8
The effects of cannabidiol on subjective states, cognition, and psychomotor function in healthy adults: A randomized clinical trial
Rudisill, T. M., Innes, K. (., Wen, S., Haggerty, T. S., & Smith, G. S. (2023) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12868 · Cited by 8
Neuropsychiatry
Fride, E., & Russo, E. B. (2005) · CRC Press eBooks · doi:10.1201/9781420023640.ch15 · Cited by 8
Neuroendocrinology and Neuroimaging Studies of Social Anxiety Disorder
Phan, K. L., & Klumpp, H. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375096-9.00010-9 · Cited by 9
Cannabidiol Modulation of Nicotine‐Induced Toxicity: Assessing Effects on Behavior, Brain‐Derived Neurotrophic Factor, and Oxidative Stress in C57BL /6 Male Mice
Mesiakaris, K., Atsopardi, Κ., Lagoumintzis, G., Margarity, M., & Poulas, K. A. (2024) · Journal of Neuroscience Research · doi:10.1002/jnr.25384 · Cited by 7
Effects of cannabidiol on fear conditioning in anxiety disorders: decreased threat expectation during retention, but no enhanced fear re-extinction
Kwee, C., van der Flier, F. E., Duits, P., van Balkom, A. J. L. M., Cath, D. C., & Baas, J. M. P. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06512-6 · Cited by 7
Cannabinoids and the Endocannabinoid System in Early SARS-CoV-2 Infection and Long COVID-19—A Scoping Review
Scott, C., Hall, S., Zhou, J., & Lehmann, C. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm13010227 · Cited by 7
Changes in Cortisol Awakening Response Before and After Development of Posttraumatic Stress Disorder, Which Cannot be Avoided with Use of Cannabidiol: A Case Report
Bolsoni, L. M., da Silva, T. D. A., Quintana, S. M., de Castro, M., Crippa, J. A. S., & Zuardi, A. W. (2019) · The Permanente Journal · doi:10.7812/tpp/18.300 · Cited by 7
The impact of cannabidiol placebo on responses to an acute stressor: A replication and proof of concept study
Zhekova, R. M., Perry, R. N., Spinella, T. C., Dockrill, K., Stewart, S. H., & Barrett, S. P. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811231219060 · Cited by 7
Wirksamkeit von Cannabidiol: Klinische Studien mit Cannabidiol und Cannabidiol-haltigen Extrakten
Büechi, S. (2017) · Schweizerische Zeitschrift für Ganzheitsmedizin / Swiss Journal of Integrative Medicine · doi:10.1159/000484886 · Cited by 7
Cannabidiol presents an inverted U-shaped dose-response curve in the simulated public speaking test
Linares, I. M. P. (2016) · doi:10.26226/morressier.5785edced462b80296c99e83 · Cited by 7
Therapeutic uses of Cannabis sativa L. Current state and future perspectives
Fraguas‐Sánchez, A. I., & Torres‐Suárez, A. I. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89867-6.00010-x · Cited by 6
Baseline affective symptomatology moderates acute subjective effects of high potency THC and CBD cannabis concentrates.
Martin‐Willett, R., Skrzynski, C. J., Karoly, H. C., Elmore, J. S., & Bidwell, L. C. (2023) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000667 · Cited by 6
The Effects of Cannabidiol on the Driving Performance of Healthy Adults: A Pilot RCT
Rudisill, T. M., Innes, K. E., Wen, S., Haggerty, T. S., & Smith, G. S. (2022) · AJPM Focus · doi:10.1016/j.focus.2022.100053 · Cited by 7
Cannabidiol in anxiety disorders: Current and future perspectives
Simei, J. L. Q., Souza, J. D. R., Lisboa, J. R., Guimarães, F. S., & Crippa, J. A. S. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.05.003 · Cited by 7
Cannabidiol attenuates prepulse inhibition disruption by facilitating TRPV1 and 5-HT1A receptor-mediated neurotransmission
Pedrazzi, J. F. C., Silva-Amaral, D., Issy, A. C., Gomes, F. V., Crippa, J. A., Guimarães, F. S., & Bel, E. D. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173879 · Cited by 7
Transtorno de ansiedade social e habilidades sociais de falar em público: estudo experimental
Angélico, A. P., Crippa, J. A. S., & Loureiro, S. R. (2012) · Estudos e Pesquisas em Psicologia · doi:10.12957/epp.2012.8302 · Cited by 6
Cannabinoids‐Human Physiology and Agronomic Principles for Production
Williams, R. A., & Williams, D. W. (2019) · ASSA, CSSA and SSSA · doi:10.2134/industrialhemp.c5 · Cited by 6
The Effect of Cannabidiol on Subjective Responses to Endurance Exercise: A Randomised Controlled Trial
McCartney, D., Irwin, C. G., Bawa, Z., Palmer, B., Sahinovic, A., Delang, N., Cox, G. R., Desbrow, B., Lau, N. S., & McGregor, I. S. (2024) · Sports Medicine - Open · doi:10.1186/s40798-024-00727-3 · Cited by 5
Differential effects of acute diazepam on emotional and neutral memory tasks in acutely hospitalized depressed patients
Delgado, V. B., Izquierdo, I., & Chaves, M. L. F. (2005) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.a792 · Cited by 5
Cannabidiol Treatment Shows Therapeutic Efficacy in a Rodent Model of Social Transfer of Pain in Pair-Housed Male Mice
Tavares, L. R. R., Petrilli, L. A., Baptista‐de‐Souza, D., Canto‐de‐Souza, L., Planeta, C. S., Guimarães, F. S., Nunes‐de‐Souza, R. L., & Canto‐de‐Souza, A. (2023) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0300 · Cited by 5
Modelling Anxiety in Humans for Drug Development
Siepmann, M., & Joraschky, P. (2007) · Current Neuropharmacology · doi:10.2174/157015907780077114 · Cited by 8
Evidence For Cannabidiol Modulation of Serotonergic Transmission in a Model of Osteoarthritis via in vivo PET Imaging and Behavioral Assessment
Ding, Y., Wang, J., Kumar, V., Ciaccio, J. A., Dakhel, S., Tan, C. S., Kim, J., Lee, S., Katz-Lichtenstein, H., Youss, Z. B., et al. (2022) · International Journal of Innovative Research in Medical Science · doi:10.23958/ijirms/vol07-i06/1418 · Cited by 4
Naturalistic examination of the anxiolytic effects of medical cannabis and associated gender and age differences in a Canadian cohort
Minhas, M., & Lunn, S. E. (2023) · Journal of Cannabis Research · doi:10.1186/s42238-023-00192-x · Cited by 4
Cannabidiol (CBD): Confronting consumers’ expectations of therapeutic benefits with pharmacological reality
Revol, B., Bagnolati, J., Micallef, J., & Jouanjus, É. (2024) · Therapies · doi:10.1016/j.therap.2024.01.006 · Cited by 4
Effects of Cannabidiol Ingestion on Thermoregulatory and Inflammatory Responses to Treadmill Exercise in the Heat in Recreationally Active Males
Johnson, D. A., Cable, T. G., Funnell, M. P., Peden, D. L., Thorley, J., CUNHA, M. F. D., Reynolds, K. M., Harris, L. G., WOOD, M., CHAVEZ-O’REILLY, T., et al. (2024) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000003568 · Cited by 4
Tetrahydrocannabinol and cannabidiol as an oromucosal spray in a 1:1 ratio: a therapeutic option for patients with central post-stroke pain syndrome?
Moser, U. (2021) · BMJ Case Reports · doi:10.1136/bcr-2021-243072 · Cited by 20
Cannabinoids and anxiety
Musty, R. E. (2005) · Birkhäuser-Verlag eBooks · doi:10.1007/3-7643-7358-x_7 · Cited by 4
Diazepam modulates hippocampal CA1 functional connectivity in people at clinical high-risk for psychosis
Livingston, N. R., Kiemes, A., O’Daly, O., Knight, S., Lukow, P. B., Jelen, L. A., Reilly, T. J., Dima, A., Nettis, M. A., Casetta, C., et al. (2025) · Psychological Medicine · doi:10.1017/s0033291725101268 · Cited by 3
Historical perspective on the therapeutic potential of cannabidiol
Guimarães, F. S. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.03.008 · Cited by 4
A nutraceutical role for cannabidiol. Why not?
Pierro, F. D. (2015) · Nutrafoods · doi:10.1007/s13749-015-0037-6 · Cited by 3
Die modifizierte Sprechangst-Anordnung
Erdmann, G., & Janke, W. (2002) · Zeitschrift für Psychologie · doi:10.1026//0044-3409.210.3.122 · Cited by 3
Recent Advances in Organometallic Reagents and Catalysts: A Concise Strategy to Synthesize Cannabinoid Natural Products
Chauhan, A. N. S., Sharma, S., Sonawane, O. A., & Erande, R. D. (2025) · ChemistrySelect · doi:10.1002/slct.202503660 · Cited by 2
CBD attenuates amygdala response to negative emotional stimuli in individuals with alcohol use disorder – a randomized controlled trial
Pfisterer, M., Teetzmann, A., Vetter, S., Baeßler, J., Schreckenberger, L., Zaiser, J., Stenger, M., & Bach, P. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06860-5 · Cited by 4
Pharmacological study of a cannabinoid-containing eyedrop formulation in dogs and mice
Stolf, A. M., Lugarini, D., de Oliveira, A., Sereniki, A., Capitelli, C. S., Tanaka, D. H., Ferreira, F. M., Vital, M. A. B. F., & Acco, A. (2015) · Journal of Applied Biomedicine · doi:10.1016/j.jab.2015.04.005 · Cited by 2
Factors Affecting Performance and Recovery in Team Sports: A Multidimensional Perspective
Bian, C. (2022) · Frontiers research topics · doi:10.3389/978-2-88974-922-5 · Cited by 2
Chemisch neuartige Tranquilizer und Hypnotika
Riederer, P. F., Laux, G., & Pöldinger, W. (1995) · Springer eBooks · doi:10.1007/978-3-7091-6593-5_5 · Cited by 2
Cannabidiol and Cannabis Use Disorder
García‐Gutiérrez, M. S., Navarrete, F., Viudez‐Martínez, A., Gasparyan, A., Caparrós, E., & Manzanares, J. (2018) · Springer eBooks · doi:10.1007/978-3-319-90365-1_5 · Cited by 2
O uso de canabinoides no tratamento da ansiedade
Zanellati, D., & Rodríguez, V. (2021) · Revista Brasileira Militar de Ciências · doi:10.36414/rbmc.v7i18.97 · Cited by 2
Associations Between Cannabis, Psychosis, and Schizophrenia in Adolescents
Moment, L., null, N., null, N., & null, N. (2022) · Academic Leadership Journal in Student Research · doi:10.58809/dbkn1868 · Cited by 1
Investigação de fatores implicados na diferença entre os sexos no reconhecimento de expressões faciais: emoção despertada e fases do ciclo menstrual
Guapo, V. G. (2013) · doi:10.11606/t.17.2013.tde-22022013-091339 · Cited by 2
The good face of Cannabis sativa: Cannabidiol
Evren, C. (2019) · Dusunen Adam The Journal of Psychiatry and Neurological Sciences · doi:10.14744/dajpns.2019.00041 · Cited by 2
Prospective Analysis of Cannabidiol's Effectiveness in Post-Exercise Recovery: An integrative Systematic Review and Research AgendaPreprint
Villalobos-González, C. E., Gómez‐Carmona, C. D., Sánchez‐Ureña, B., Azofeifa-Mora, C., & Rojas‐Valverde, D. (2024) · Preprints.org · doi:10.20944/preprints202405.0517.v1 · Cited by 1
The Safety and Efficacy of CBD—A Pharmacist’s Perspective
Maaiah, S., Nguyen, A., Senovaityte, S., Dang, L., & Gharibyar, H. (2021) · Pharmacology & Pharmacy · doi:10.4236/pp.2021.128015 · Cited by 1
Cannabis and Neuropsychiatric Effects
Rettew, D. C., Gundersen, D. C., Rapp, E. K., Riggs, P., Miller, C. L., Jackson, M., Sabet, K. A., Cort, B., & Bader, L. L. (2020) · Springer eBooks · doi:10.1007/978-3-030-45968-0_4 · Cited by 1
Cannabidiol safety
Charrette, A., Akingbasote, J. A., Guthrie, N., & Hilmas, C. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821038-3.00039-2 · Cited by 1
From Bud to Brain: A Psychiatrist's View of Marijuana
Cermak, T. L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108653428 · Cited by 1
L’usage du cannabidiol dans le sport : une bonne idée ?
Gamelin, F.-X., Berthoin, S., Cuvelier, G., Mendes, A., Anthierens, A., & Heyman, E. (2021) · Science & Sports · doi:10.1016/j.scispo.2021.03.003 · Cited by 2
Cannabinoids and Neuropsychiatry
JAMES, S. P. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108583336.008 · Cited by 1
Dental Anxiety Management by Full Spectrum CBD Formulations: Dual Dosing (AM/PM) Protocol in A Real-World Setting
Cooper, D. L., Stephan, R., & Maygar, C. W. (2021) · Clinics in Medicine · doi:10.33597/2688-6731-v3-id1038 · Cited by 1

Authors: Zuardi, A. W., Cosme, R. A., Graeff, F. G., & Guimarães, F. S.
Affiliations: Universidade de São Paulo (BR)
ORCID: Zuardi, A. W.
Graeff, F. G.
Venue: Journal of Psychopharmacology
Publisher: SAGE Publications
Published: 1993-01
Volume: 7
Issue: 1_suppl
Pages: 82-88
ISSN: 0269-8811 (ISSN-L)
1461-7285
DOI: 10.1177/026988119300700112
OpenAlex: W1696206979
Cited by: 364
References: 39
Citations by year: 2026: 4 · 2025: 10 · 2024: 33 · 2023: 28 · 2022: 37 · 2021: 28 · 2020: 43 · 2019: 25 · 2018: 11 · 2017: 21 · 2016: 12 · 2015: 12 · 2014: 9 · 2013: 10 · 2012: 17
FWCI: 2.33
Type: journal article
Language: en
Open access: closed
Licence: journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations: Journal of Psychopharmacology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plant Extracts Effects
Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords: ipsapirone, cannabidiol, diazepam, anxiety, anxiolytic effects, stress response, blood pressure, sedation, healthy volunteers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effects of ipsapirone and cannabidiol on human experimental anxiety

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks